Who can safely discontinue lifelong follow‐up among patients with sporadic pheochromocytoma and paraganglioma?
This study suggests that routine lifelong follow-up may be unnecessary for patients with sporadic PCC aged >40 years, size <6 cm, and PASS <4 or GAPP score <3.
Authors
- Sara Talvacchio (ORCID: https://orcid.org/0009-0006-6969-4735)
- Jae-Kyung Won
- Seung Shin Park (ORCID: https://orcid.org/0000-0001-5719-1539)
- Tamara Prodanov (ORCID: https://orcid.org/0009-0007-3887-5303)
- Won Woong Kim (ORCID: https://orcid.org/0000-0003-3471-2068)
- Hussam Alkaissi (ORCID: https://orcid.org/0000-0002-0861-9348)
- Seung Hun Lee (ORCID: https://orcid.org/0000-0001-5122-9487)
- Jung-Min Koh
- Yu-Mi Lee
- Kyu Eun Lee
- Su-Jin Kim
- Min Jeong Park
- Tae-Yon Sung
- Dong Eun Song
- Karel Pacak
- Jung Hee Kim
Institutions
- Ulsan College (KR)
- Seoul National University (KR)
- Korea University Medical Center (KR)
- Asan Medical Center (KR)
- Seoul National University Hospital (KR)
- University of Ulsan (KR)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- Institute of Endocrinology (CZ)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (US)
- Palacký University Olomouc (CZ)
- Comenius University Bratislava (SK)
Publication Details
- Journal
- Journal of Internal Medicine
- Published
- 2026-03-04
- DOI
- https://doi.org/10.1111/joim.70080
- Primary Topic
- Adrenal and Paraganglionic Tumors
- Type
- article
- Field-Weighted Citation Impact
- 0.00